Strategic Planning Checklist for Neurodegeneration Studies

This checklist serves as a guide for strategic planning in neurodegeneration studies, focusing on the complexities involved in conducting such research. It outlines critical considerations for site infrastructure, participant selection, and the involvement of study partners. The document emphasizes the importance of having access to the right population of participants and specialist testing facilities, as well as the need for validated translations of Clinical Outcomes Assessment (COA) scales. It also addresses the significance of understanding the caregiver's role and the emotional and societal impacts on study partners. Furthermore, the checklist highlights the necessity of ensuring compliance with regulatory standards for biomarkers and the importance of clear participant instructions. Each aspect is aimed at optimizing trial outcomes and enhancing participant recruitment and retention. The document provides a structured approach to navigating the complexities of neurodegenerative research, ensuring that all critical factors are considered during the planning phase.